pfizer stock was soaring after the company said its covid19 pill cut the risk of hospitalization or death by 89 in a trial of highrisk nonhospitalized adults besting by a substantial margin the efficacy of merck‘s highlytouted covid19 pill molnupiravir shares of pfizer ticker pfe soared 95 in premarket trading friday while merck mrk shares dropped 72